MEA Lymphedema Treatment Market - Industry Trends and Forecast to 2033
Middle East and Africa lymphedema treatment market is expected to reach USD 15,432.53 thousand by 2030 from USD 10,003.92 thousand in 2022 growing at the CAGR of 5.8% in the forecast period of 2023 to 2030.The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.
Market Segmentation:
Middle East and Africa Lymphedema Treatment Market, By Treatment Type (Compression Therapy, Surgery, Drug Therapy, Laser Therapy, and Others), Treatment (Primary Lymphedema and Secondary Lymphedema), Affected Area (Genital, Lower Extremity, Upper Extremity, and Others), Age Group (Adult and Geriatric), Route of Administration (Oral, Injectable, and Others), End User (Hospitals, Ambulatory Surgical Centres, Speciality Clinics, and Others), Distribution Channel (Direct tender, Pharmacy stores, and Others), Country (South Africa, Saudi Arabia, U.A.E., Kuwait, Israel, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2030
Overview of Middle East and Africa Lymphedema Treatment Market Dynamics
Driver
• Rising number of lymphedema cases around the globe
Restrain
• High costs of treatment
Opportunity
• Partnership and agreement by market players
Market PlayersSome of the key market players operating in the Middle East and Africa lymphedema treatment market are listed below:• PAUL HARTMANN AG
• 3M
• Convatec Inc.
• JUZO
• SIGVARIS GROUP
• Tactile Medical
• BIOCOMPRESSION SYSTEMS
• Lohmann & Rauscher GmbH & Co. KG
• ThermoTek
• Cardinal Health
• Essity (BSN medical GmbH)
• Smith+Nephew
• HERANTIS PHARMA Plc
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.